NUPR1 and prostate carcinoma: Schnepp et al. (Schnepp et al. 2020) performed scRNA-seq on docetaxel-sensitive and docetaxel-resistant mutants of DU145 and PC3 prostate cancer cell lines to determine that nuclear protein 1 (NUPR1) is a driver of docetaxel resistance.